We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Kim Boericke, the new CEO at Veristat! In this episode, I sit down with Kim to explore what it really takes to build and lead a durable CRO in a rapidly shifting life sciences landscape. We discuss Kim’s leadership journey, how value is created and captured in services-heavy businesses, and what Veristat is prioritizing for customers over the next 12 months. The conversation then goes deeper into the idea of moats—what makes a CRO genuinely hard to copy, what compounds over time, and how strategic decisions today shape defensibility five years out.
Check out the main topics of discussion for this episode of the Life Sciences Today podcast:
- Tell me about your journey.
- How do you create value for your customers?
- How do you capture the value?
- What are three things you’d like to achieve in the next 12-18 months?
- What makes a CRO genuinely hard to copy?
- What compounds over time? How do the strategic decisions you make today shape out defensibility five years from now?
Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.
Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:
Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.
If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.
Thanks so much for listening!
No comments:
Post a Comment